Published in Medicine (Baltimore) on February 01, 2017
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol (2009) 5.57
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol (2009) 5.42
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37
Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. Br J Surg (1997) 2.18
Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol (2004) 1.69
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg (1985) 1.65
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg (2003) 1.56
Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg (1995) 1.54
Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer (2007) 1.16
Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer (2002) 1.14
Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc (2011) 1.04
Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? World J Gastroenterol (2015) 0.83
The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) (2016) 0.77
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases. Ann Coloproctol (2016) 0.77
Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg (2016) 0.77
Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases. Br J Surg (2016) 0.76
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol (2010) 5.51
Prolongation of the period between biopsy and EMR can influence the nonlifting sign in endoscopically resectable colorectal cancers. Gastrointest Endosc (2008) 3.05
Clinical practice guideline: Polysomnography for sleep-disordered breathing prior to tonsillectomy in children. Otolaryngol Head Neck Surg (2011) 1.96
Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg (2010) 1.65
Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg (2007) 1.60
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.53
Chronological improvement in survival following rectal cancer surgery: a large-scale, single-center study. World J Surg (2013) 1.45
Clinical practice guideline: Tympanostomy tubes in children. Otolaryngol Head Neck Surg (2013) 1.44
Succinylcholine Use and Dantrolene Availability: Reply. Anesthesiology (2019) 1.39
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 1.33
Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol (2007) 1.23
Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Colorectal Dis (2007) 1.23
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet (2003) 1.21
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clin Cancer Res (2006) 1.18
Learning curves for laparoscopic sigmoidectomy used to manage curable sigmoid colon cancer: single-institute, three-surgeon experience. Surg Endosc (2008) 1.18
The impact of obesity on outcomes of laparoscopic surgery for colorectal cancer in Asians. Surg Endosc (2009) 1.16
Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum (2007) 1.13
Clinicopathological characteristics of rectal carcinoids. Int J Colorectal Dis (2010) 1.13
Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys (2009) 1.13
Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Ann Surg Oncol (2010) 1.13
Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg (2010) 1.10
Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol (2007) 1.08
Laparoscopic-assisted combined colon and liver resection for primary colorectal cancer with synchronous liver metastases: initial experience. World J Surg (2008) 1.08
Effectiveness of biofeedback therapy in the treatment of anterior resection syndrome after rectal cancer surgery. Dis Colon Rectum (2011) 1.08
Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol (2011) 1.07
Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients. J Surg Oncol (2013) 1.07
Mach-Zehnder interferometer formed in a photonic crystal fiber based on a pair of long-period fiber gratings. Opt Lett (2004) 1.06
An ultraviolet-curable mold for sub-100-nm lithography. J Am Chem Soc (2004) 1.05
Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys (2008) 1.04
Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging. Am J Surg (2006) 1.04
Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam Cancer (2004) 0.99
Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Dis Colon Rectum (2009) 0.99
Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis (2009) 0.99
Steroid-refractory cryptogenic multifocal ulcerous stenosing enteritis. Am J Surg (2011) 0.98
Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res (2005) 0.98
Surgical outcomes after total colectomy with ileorectal anastomosis in patients with medically intractable slow transit constipation. J Korean Soc Coloproctol (2011) 0.98
Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay. Int J Colorectal Dis (2008) 0.97
Colonoscopy in situs inversus totalis patients. Am J Gastroenterol (2008) 0.97
Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys (2005) 0.96
Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study. Int J Radiat Oncol Biol Phys (2010) 0.96
[Clinical features and prognostic factors in primary adenocarcinoma of the appendix]. Korean J Gastroenterol (2004) 0.96
Characteristics and risk factors associated with permanent stomas after sphincter-saving resection for rectal cancer. World J Surg (2013) 0.96
Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2009) 0.96
Synchronous penile metastasis from a rectal carcinoma. Int J Colorectal Dis (2007) 0.96
Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Hum Pathol (2005) 0.96
Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J Clin Pathol (2006) 0.96
Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer. Clin Cancer Res (2011) 0.96
Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer (2006) 0.95
Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer. J Korean Soc Coloproctol (2012) 0.94
Atypical endoscopic features can be associated with metastasis in rectal carcinoid tumors. Surg Endosc (2008) 0.94
D3 lymphadenectomy using a medial to lateral approach for curable right-sided colon cancer. Int J Colorectal Dis (2008) 0.92
Abdominoperineal resection and low anterior resection: comparison of long-term oncologic outcome in matched patients with lower rectal cancer. Int J Colorectal Dis (2012) 0.92
MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD/BMD. BMC Med Genet (2013) 0.92
Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin Cancer Res (2003) 0.91
Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy? Histopathology (2011) 0.90
Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability. Int J Colorectal Dis (2002) 0.90
Evaluation of myenteric ganglion cells and interstitial cells of Cajal in patients with chronic idiopathic constipation. Int J Colorectal Dis (2002) 0.89
Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg (2008) 0.89
Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy. J Gastrointest Surg (2012) 0.89
Intra-abdominal fistulas in surgically treated Crohn's disease patients. World J Surg (2010) 0.89
Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer. Cancer Sci (2011) 0.89
Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat (2005) 0.89
Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors. Cancer Sci (2008) 0.89
Three novel mutations of the APC gene in Korean patients with familial adenomatous polyposis. Cancer Genet Cytogenet (2010) 0.89
Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study. Int J Radiat Oncol Biol Phys (2010) 0.88
Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria. Clin Cancer Res (2004) 0.88
Robust microsatellite instability (MSI) analysis by denaturing high-performance liquid chromatography (DHPLC). J Hum Genet (2003) 0.88
Genome-wide identification of chemosensitive single nucleotide polymorphism markers in colorectal cancers. Cancer Sci (2009) 0.88
Feasibility of single-stage laparoscopic resection after placement of a self-expandable metallic stent for obstructive left colorectal cancer. World J Surg (2008) 0.88
Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization. Clin Chem (2004) 0.88
Risk factors for complications after bowel surgery in Korean patients with Crohn's disease. J Korean Surg Soc (2012) 0.88
Colonic J-pouch anal anastomosis after ultralow anterior resection with upper sphincter excision for low-lying rectal cancer. World J Gastroenterol (2005) 0.87
CT colonography after metallic stent placement for acute malignant colonic obstruction. Radiology (2010) 0.87
The Role of Diverting Stoma After an Ultra-low Anterior Resection for Rectal Cancer. Ann Coloproctol (2013) 0.87
Evaluation of calgranulin B in stools from the patients with colorectal cancer. Dis Colon Rectum (2008) 0.86
Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis. J Surg Oncol (2013) 0.86
Ovarian metastases from colorectal cancer: a clinicopathological analysis of 103 patients. Colorectal Dis (2008) 0.85
Role of surgery in the treatment of ovarian metastases from colorectal cancer. J Surg Oncol (2009) 0.85
MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas. Virchows Arch (2007) 0.84
Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg (2011) 0.84
The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation. J Surg Oncol (2010) 0.84
Identification of mitochondrial FoF1-ATP synthase involved in liver metastasis of colorectal cancer. Cancer Sci (2007) 0.83
Novel single-nucleotide polymorphism markers predictive of pathologic response to preoperative chemoradiation therapy in rectal cancer patients. Int J Radiat Oncol Biol Phys (2013) 0.83
Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis. Am J Surg (2013) 0.83
Completely abdominal intersphincteric resection for lower rectal cancer: feasibility and comparison of robot-assisted and open surgery. Surg Endosc (2014) 0.83
Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer. J Surg Oncol (2006) 0.83
Risk factors for anastomotic leakage after resection for rectal cancer. Hepatogastroenterology (2006) 0.82
Cefotetan versus conventional triple antibiotic prophylaxis in elective colorectal cancer surgery. J Korean Med Sci (2010) 0.82
Conservative management of adhesive small bowel obstructions in patients previously operated on for primary colorectal cancer. J Gastrointest Surg (2007) 0.82
Clinical practice guideline: tympanostomy tubes in children--executive summary. Otolaryngol Head Neck Surg (2013) 0.81
A comparison of the technical and oncologic validity between robot-assisted and conventional open abdominoperineal resection. Int J Colorectal Dis (2014) 0.81